TrialCellular & molecular immunology2015

Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial.

Soyoung Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.